Huiyan Bio
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- Undisclosed
Investors
- 1
About Huiyan Bio
Based in Wuhan, China, and established in 2013, Huiyan Bio operates as a biotechnology company that focuses on providing mediums and equipment used in separation and purification. The company passed the ISO9001 system certification and was recognized as the National High-tech Enterprise. It also acquired 6 invention patents. Huiyan Bio mainly provides technical services such as protein, antibody, peptide, and nucleic acid isolation and purification. The company mainly provides gel filtration, ion exchange, and hydrophobic chromatography media, and chromatography columns. Agarose gel filtration medium, Focurose 4B, is suitable for the separation of components and medium purification of biomolecular substances, such as virus particles and recombinant hepatitis B surface antigen. Its products and services can be used in biotechnology, biopharmaceuticals, diagnostic reagents, biologics, and medical devices.
Who invested in Huiyan Bio
1 investor across 1 round
See all investors in Huiyan Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 26, 2020
Amount
Undisclosed
Investors
Questions about Huiyan Bio
Who invested in Huiyan Bio?
Huiyan Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huiyan Bio raised?
Huiyan Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Huiyan Bio last raise money?
Huiyan Bio's most recent round on record is a Series A, in Nov 2020.
What does Huiyan Bio do?
Based in Wuhan, China, and established in 2013, Huiyan Bio operates as a biotechnology company that focuses on providing mediums and equipment used in separation and purification.
Where is Huiyan Bio headquartered?
Huiyan Bio is headquartered in Wuhan, China.
Which VCs invest in companies like Huiyan Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Huiyan Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Huiyan Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.